コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 from 50.0% (alcohol use disorder) to 89.2% (generalized anxiety disorder).
2 disorder, major depressive disorder, and/or generalized anxiety disorder).
3 ncluding major depressive disorder (MDD) and generalized anxiety disorder.
4 ed to self-reported anxiety in patients with generalized anxiety disorder.
5 expressions in generalized social phobia and generalized anxiety disorder.
6 ients with generalized social phobia without generalized anxiety disorder.
7 ions differ in generalized social phobia and generalized anxiety disorder.
8 tolerated short-term treatment for pediatric generalized anxiety disorder.
9 se venlafaxine in the treatment of pediatric generalized anxiety disorder.
10 ) at age 45 years for depressive episode and generalized anxiety disorder.
11 een healthy adolescents and adolescents with generalized anxiety disorder.
12 -based decision making have been reported in generalized anxiety disorder.
13 efficacious and well-tolerated treatment for generalized anxiety disorder.
14 s studied for the treatment of patients with generalized anxiety disorder.
15 ixed doses of paroxetine in the treatment of generalized anxiety disorder.
16 eliminated for all anxiety disorders except generalized anxiety disorder.
17 nd 3) those with neither DSM-IV nor modified generalized anxiety disorder.
18 tive, rapidly acting, and safe treatment for generalized anxiety disorder.
19 tional impairments during decision making in generalized anxiety disorder.
20 disorder, posttraumatic stress disorder, and generalized anxiety disorder.
21 ties of 0.43 for panic disorder and 0.32 for generalized anxiety disorder.
22 thymia, social phobia, major depression, and generalized anxiety disorder.
23 nts with major depression with and without a generalized anxiety disorder.
24 therapeutic effects on major depression and generalized anxiety disorder.
25 and expected reinforcement) is disrupted in generalized anxiety disorder.
26 episode, phobias, alcohol use disorders, and generalized anxiety disorder.
27 and function have focused on depression and generalized anxiety disorder.
28 was major depressive disorder with comorbid generalized anxiety disorder.
29 se and prevents relapse in older adults with generalized anxiety disorder.
30 to predict new onset of specific phobia and generalized anxiety disorder.
31 nts with social phobia, and adolescents with generalized anxiety disorder.
32 nstructed emotion regulation is perturbed in generalized anxiety disorder.
33 cipatory processes in the pathophysiology of generalized anxiety disorder.
34 outcomes, or worry, is a cardinal symptom of generalized anxiety disorder.
35 mptoms in post-traumatic stress disorder and generalized anxiety disorders.
36 e hypothesis that it predicts depressive and generalized anxiety disorders.
37 ic illness: major depressive disorder (27%), generalized anxiety disorder (10%), panic disorder (10%)
38 depressive disorder] and 43 (5.3%) for GAD [generalized anxiety disorder] (11 [1.4%] had comorbidity
39 mental health (major depressive episode and generalized anxiety disorder), (2) substance use (smokin
40 ve disorder: 1) those with coexisting DSM-IV generalized anxiety disorder, 2) those with coexisting m
41 h Questionnaire-2 for depression, a two-item Generalized Anxiety Disorder-2 questionnaire for anxiety
42 ; 95% confidence interval [CI], 1.53-30.17), generalized anxiety disorder (20.5% vs 3.71%; OR, 5.53;
43 major depression (32 versus 7%, P < 0.0001), generalized anxiety disorder (21 versus 2%, P < 0.005),
44 sorder (7.3%), alcohol use disorders (5.2%), generalized anxiety disorder (3.7%), and panic disorder
45 s disorder, 4.0% (95% CI, 1.7% to 7.7%), and generalized anxiety disorder, 3.5% (95% CI, 1.4% to 7.1%
46 ring neuroses were depressive episode (37%), generalized anxiety disorder (31%), agoraphobia or panic
47 12.6%), panic disorder (24.8% versus 4.0%), generalized anxiety disorder (38.6% versus 8.4%), and al
48 Patterns of comorbidity for panic (51%), generalized anxiety disorder (55%), and major depression
49 ress disorder, 7.6% (CI, 5.9% to 9.4%) had a generalized anxiety disorder, 6.8% (CI, 5.3% to 8.6%) ha
50 and 14.7%, respectively; suicidality, 20.2%; generalized anxiety disorder, 7.9%; posttraumatic stress
51 Panic attacks occurred in five patients with generalized anxiety disorder (71%) and in one normal sub
53 e 5-17 years who met the DSM-IV criteria for generalized anxiety disorder according to the Anxiety Di
54 ltiple neuropsychiatric disorders, including generalized anxiety disorders, addiction, schizophrenia,
55 7, for selected 12-month anxiety disorders (generalized anxiety disorder, agoraphobia, and social ph
56 phrenia, bipolar disorder, major depression, generalized anxiety disorder, agoraphobia, social phobia
57 ce associations with most mood disorders and generalized anxiety disorder also remained significant.
59 pressed patients with and without a comorbid generalized anxiety disorder, although time to recovery
60 mary trials of interest, 18 adolescents with generalized anxiety disorder and 15 comparison subjects
62 " To test this, we recruited 32 females with generalized anxiety disorder and 25 age-matched healthy
64 THOD: Forty-six unmedicated individuals with generalized anxiety disorder and 32 healthy comparison s
65 c neuralgia, diabetic peripheral neuropathy, generalized anxiety disorder and adjunctive therapy for
66 loading most heavily on major depression and generalized anxiety disorder and another loading most st
67 reat cues differentially in adolescents with generalized anxiety disorder and in healthy adolescents.
68 suggest an association between treatment for generalized anxiety disorder and lower risk of depressio
69 Development in the United States Survey for generalized anxiety disorder and major depression at 12
70 pression only, and 25 patients with comorbid generalized anxiety disorder and major depression were s
71 used to obtain diagnostic classifications of generalized anxiety disorder and major depressive disord
72 the DSM-IV hierarchical relationship between generalized anxiety disorder and mood disorders, the aut
73 e used to decompose the correlations between generalized anxiety disorder and neuroticism into geneti
74 l-specific environmental correlation between generalized anxiety disorder and neuroticism was estimat
76 emoved from the models, correlations between generalized anxiety disorder and neuroticism were estima
79 and placebo were evaluated in patients with generalized anxiety disorder and normal comparison subje
80 mygdala responses to anticipatory signals in generalized anxiety disorder and of anterior cingulate c
82 ence of internalizing disorders (depression, generalized anxiety disorder and post-traumatic stress d
83 ow risk vs moderate/high risk), past 6-month generalized anxiety disorder and posttraumatic stress di
85 pernicious effect of PersDs on the course of generalized anxiety disorder and social phobia but not p
86 onship between major depressive disorder and generalized anxiety disorder and suggest that the exclus
87 examined the sources of covariation between generalized anxiety disorder and the personality trait o
88 r or having been prescribed a medication for generalized anxiety disorder and the risk of depression.
89 tion between specific forms of treatment for generalized anxiety disorder and the risk of major depre
90 ermine the association between treatment for generalized anxiety disorder and the risk of major depre
91 treatment of psychic and somatic symptoms of generalized anxiety disorder and was well tolerated by m
92 older with a DSM-IV anxiety disorder (mainly generalized anxiety disorder) and a Hamilton Anxiety Rat
93 disorder, 2) those with coexisting modified generalized anxiety disorder, and 3) those with neither
94 ocial phobia, posttraumatic stress disorder, generalized anxiety disorder, and obsessive-compulsive d
95 e, major depressive episode, phobias, panic, generalized anxiety disorder, and obsessive-compulsive d
97 ent an important advance in the treatment of generalized anxiety disorder, and perhaps other anxiety
100 associated with benefits in the treatment of generalized anxiety disorder, and risperidone was associ
101 ers, notably substance dependence, panic and generalized anxiety disorder, and several personality di
102 r antagonists for major depressive disorder, generalized anxiety disorder, and social anxiety disorde
104 , individual medical conditions, depression, generalized anxiety disorder, and substance use disorder
105 s disorder (PTSD), major depressive episode, generalized anxiety disorder, and suicidality, as well a
106 tric disorders (major depression, dysthymia, generalized anxiety disorders, and panic attacks) and dr
108 s well as dependence with mood disorders and generalized anxiety disorder, appears to be due in part
110 ctivation in this region in adolescents with generalized anxiety disorder as well as healthy adolesce
111 This is the first evidence in juveniles that generalized anxiety disorder-associated patterns of path
114 ated with elevated adjusted odds of PTSD and generalized anxiety disorder at T2 and T3 and of major d
116 e adolescents-14 with social phobia, 18 with generalized anxiety disorder but not social phobia, and
117 -ANX, comorbid major depressive disorder and generalized anxiety disorder can be accurately predicted
119 e treatment of children and adolescents with generalized anxiety disorder, depression, obsessive comp
120 ractivity disorder, hypertension, depression/generalized anxiety disorder, diabetes mellitus, gastroe
122 all difference was that major depression and generalized anxiety disorder dimensions had small but si
123 essive disorder who met all the criteria for generalized anxiety disorder except for the exclusion cr
124 rs, the authors made a diagnosis of modified generalized anxiety disorder for patients with major dep
125 total of 1,614 individuals with and without generalized anxiety disorder from a psychiatric clinic a
126 on regulation deficits figure prominently in generalized anxiety disorder (GAD) and in other anxiety
129 ce imaging (fMRI) data from individuals with generalized anxiety disorder (GAD) and panic disorder (P
139 therapy (CBT) can be effective for late-life generalized anxiety disorder (GAD), but only pilot studi
140 Post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD), eg, share elevated a
141 imaging study was conducted of patients with generalized anxiety disorder (GAD), major depressive dis
142 tients with cardiac disease with depression, generalized anxiety disorder (GAD), or panic disorder; u
143 bed in posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), panic disorder (PD),
144 itioning studies assessing generalization in generalized anxiety disorder (GAD), results of this meta
147 1522, age 32-72 years) were administered the Generalized Anxiety Disorder (GAD-7) instrument, whole b
152 depressed patients with DSM-IV and modified generalized anxiety disorder had higher levels of suicid
153 This study tested whether patients with generalized anxiety disorder have alterations in anticip
156 e experiences that increase vulnerability to generalized anxiety disorder, however, have only modest
157 of symptoms that met inclusion criteria for generalized anxiety disorder in a depressive episode.
158 of OCD, social phobia, specific phobia, and generalized anxiety disorder in childhood, before they d
159 is safe and efficacious for the treatment of generalized anxiety disorder in children and adolescents
160 e inhibitor, and placebo in the treatment of generalized anxiety disorder in children and adolescents
161 ological worry; and a higher morbid risk for generalized anxiety disorder in first-degree family memb
163 rated option for the short-term treatment of generalized anxiety disorder in outpatients without majo
164 , specifically of social situations, whereas generalized anxiety disorder involves intrusive worry ab
165 ticism and those that increase liability for generalized anxiety disorder, irrespective of gender.
166 cataplexy, dysthymic disorder, fibromyalgia, generalized anxiety disorder, irritable bowel syndrome,
169 r depression and that the role impairment of generalized anxiety disorder is comparable to that of ma
170 t or whether the impairment of patients with generalized anxiety disorder is due to depression or oth
171 ed collaborative care for panic disorder and generalized anxiety disorder is more effective than usua
174 ve to the comparison subjects, patients with generalized anxiety disorder manifested greater right ve
175 Symptoms that met inclusion criteria for generalized anxiety disorder, measured separately, were
177 udied obsessive-compulsive disorder (n = 4), generalized anxiety disorder (n = 2), attention-deficit/
180 ender with generalized social phobia without generalized anxiety disorder (N=17), generalized anxiety
181 without generalized anxiety disorder (N=17), generalized anxiety disorder (N=17), or no psychopatholo
182 re individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited f
183 panic disorder with or without agoraphobia, generalized anxiety disorder, obsessive-compulsive disor
184 se results show that a substantial amount of generalized anxiety disorder occurs independently of maj
185 3, 95% confidence interval [CI]=1.00-1.78]), generalized anxiety disorder (odds ratio=1.72, 95% CI=1.
186 t depression plus anxiety (specifically GAD [generalized anxiety disorder]) (odds ratio, 468.53) or d
187 f neuroticism and twice the risk of lifetime generalized anxiety disorder of men, gender-specific eff
188 ealthy comparison subjects, 18 patients with generalized anxiety disorder only, 14 patients with majo
189 having seen a mental health professional for generalized anxiety disorder or having been prescribed a
190 n that lifetime DUD was also associated with generalized anxiety disorder (OR, 1.3; 95% CI, 1.06-1.49
191 ith friends: OR, 6.26 [95% CI, 3.07-12.76]), generalized anxiety disorder (OR, 5.19 [95% CI, 2.01-13.
192 , social anxiety disorder, specific phobias, generalized anxiety disorder, or separation anxiety and
193 ry diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia to receiv
196 Lifetime diagnoses for 6 anxiety disorders (generalized anxiety disorder, panic disorder, agoraphobi
198 "internalizing" (major depression, phobias, generalized anxiety disorder, panic disorder, and bulimi
199 esonance imaging (fMRI) was employed with 14 generalized anxiety disorder patients and 12 healthy com
200 cortex and hippocampus of 15 medication-free generalized anxiety disorder patients and 15 age- and se
204 the following 7 syndromes: major depression, generalized anxiety disorder, phobia, alcohol dependence
205 m family and twin studies of panic disorder, generalized anxiety disorder, phobias, and obsessive-com
207 jor depressive disorder, dysthymic disorder, generalized anxiety disorder, posttraumatic stress disor
208 iety, fear, and social dysfunctions, such as generalized anxiety disorder, posttraumatic stress disor
209 agoraphobia, specific phobia, social phobia, generalized anxiety disorder, posttraumatic stress disor
210 ted using a larger number of substances, and generalized anxiety disorder predicted having more depen
211 Drugs that are clinically effective against generalized anxiety disorder preferentially alter rodent
213 17 years of age who met DSM-IV criteria for generalized anxiety disorder received a flexible dosage
215 ealed that during feedback, individuals with generalized anxiety disorder relative to healthy subject
216 a PersD predicted a 30% lower likelihood of generalized anxiety disorder remission, a 39% lower like
217 The best-performing test for GAD was the Generalized Anxiety Disorder Scale 7 Item (GAD-7), with
218 ite score for nine delineated items from the generalized anxiety disorder section of a modified versi
219 nds with an anxiety disorder (social phobia, generalized anxiety disorder, separation anxiety disorde
220 ants for conduct disorder, major depression, generalized anxiety disorder, separation anxiety disorde
221 mants for conduct disorder,major depression, generalized anxiety disorder, separation anxiety disorde
224 These data demonstrate that patients with generalized anxiety disorder show significant deficits i
228 ients with generalized social phobia without generalized anxiety disorder showed increased activation
231 least 1 of the following anxiety disorders: generalized anxiety disorder, social anxiety disorder, s
232 ents who were diagnosed with panic disorder, generalized anxiety disorder, social phobia, and/or post
233 le diagnoses of separation anxiety disorder, generalized anxiety disorder, social phobia, major depre
234 ersDs) on time to remission in patients with generalized anxiety disorder, social phobia, or panic di
235 pisode and dysthymia) and anxiety disorders (generalized anxiety disorder, social phobia, panic disor
236 epression symptoms were only associated with generalized anxiety disorder symptoms in childhood (r =
237 onal numbing, major depressive disorder, and generalized anxiety disorder symptoms) symptoms as asses
238 Compared to the depressed patients without generalized anxiety disorder, the depressed patients wit
239 preclinical procedures and in patients with generalized anxiety disorder, the most common of the anx
241 isorder, social phobia, specific phobias and generalized anxiety disorder--these responses are exagge
243 n, 20 (17%) for panic disorder, 20 (17%) for generalized anxiety disorder, two (2%) for alcohol abuse
245 ression; the association with persistence of generalized anxiety disorder was nearly significant.
246 ically, a lower likelihood of remission from generalized anxiety disorder was predicted by the presen
248 Comorbid anxiety disorders and symptoms of generalized anxiety disorder were associated with a more
250 AUD and panic disorder, specific phobia, and generalized anxiety disorder were modest (odds ratios ra
252 domized language groups: Lifetime reports of generalized anxiety disorder were more prevalent in the
253 his double-blind study, patients with DSM-IV generalized anxiety disorder were randomly assigned to r
254 adults aged 18 to 64 years with panic and/or generalized anxiety disorder who were recruited from Jul
255 neralized anxiety syndrome (GAS) (defined as generalized anxiety disorder with a 2-week minimum durat
256 release (XR) venlafaxine in outpatients with generalized anxiety disorder without concomitant major d
257 cessing contribute to the pathophysiology of generalized anxiety disorder, yet these abnormalities re
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。